Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/143125| Title: | Drug repurposing |
| Authors: | Grech, Alfred Farrugia, Mario Balzan, Michael |
| Keywords: | Drug repositioning Drug development Pharmaceutical industry -- Economic aspects Drugs -- Research |
| Issue Date: | 2023 |
| Publisher: | Malta Leadership Institute (MLI) |
| Citation: | Grech, A., Farrugia, M., & Balzan, M. (2023). Drug repurposing. The Synapse : the Medical Professionals' Network, 22(1), 24-27. |
| Abstract: | The discovery and development of new drugs is slow, time-consuming and costly. An increasingly attractive option is ‘repurposing’, which is the process of finding new uses for existing drugs. This proposition of repurposing (also called ‘drug repositioning’) has spurred the research community as it has a promising potential to fast track already used drugs into clinical studies for new clinical indications. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/143125 |
| Appears in Collections: | The Synapse, Volume 22, Issue 1 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| TheSynapse22(1)A5.pdf | 280.99 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.